Have a feature idea you'd love to see implemented?
Let us know!
VOR Vor Biopharma Inc
Price (delayed)
$0.718
Market cap
$49.11M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.73
Enterprise value
$4.44M
Vor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that
Highlights
VOR's EPS is up by 15% YoY and by 2.3% from the previous quarter
The debt is down by 10% YoY and by 2.6% from the previous quarter
Vor Biopharma's quick ratio has plunged by 57% YoY and by 23% from the previous quarter
Vor Biopharma's equity has plunged by 52% YoY and by 20% from the previous quarter
Key stats
What are the main financial stats of VOR
Market
Valuations
Earnings
Shares outstanding
68.4M
Market cap
$49.11M
Enterprise value
$4.44M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.5
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$118.09M
EBITDA
-$109.6M
Free cash flow
-$104.94M
Per share
Balance sheet
Liquidity
EPS
-$1.73
Free cash flow per share
-$1.54
Book value per share
$1.44
Revenue per share
$0
TBVPS
$2.07
Total assets
$141.59M
Total liabilities
$43.51M
Debt
$33.82M
Equity
$98.08M
Working capital
$76.46M
Debt to equity
0.34
Current ratio
6.54
Quick ratio
6.4
Net debt/EBITDA
0.41
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-64.7%
Return on equity
-86.4%
Return on invested capital
-78%
Return on capital employed
-92.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VOR stock price
How has the Vor Biopharma stock price performed over time
Intraday
1.01%
1 week
6.32%
1 month
-13.49%
1 year
-65.48%
YTD
-68.09%
QTD
2.57%
Financial performance
How have Vor Biopharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$124.8M
Net income
-$118.09M
Gross margin
N/A
Net margin
N/A
The company's operating income fell by 12% YoY but it rose by 2.5% QoQ
The net income has contracted by 11% YoY
Growth
What is Vor Biopharma's growth rate over time
Valuation
What is Vor Biopharma stock price valuation
P/E
N/A
P/B
0.5
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
VOR's EPS is up by 15% YoY and by 2.3% from the previous quarter
Vor Biopharma's equity has plunged by 52% YoY and by 20% from the previous quarter
VOR's price to book (P/B) is 51% less than its last 4 quarters average of 1.0
Efficiency
How efficient is Vor Biopharma business performance
The return on invested capital has dropped by 72% year-on-year and by 24% since the previous quarter
The company's return on equity has shrunk by 72% YoY and by 17% QoQ
The return on assets has dropped by 58% year-on-year and by 13% since the previous quarter
Dividends
What is VOR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VOR.
Financial health
How did Vor Biopharma financials performed over time
Vor Biopharma's current ratio has plunged by 57% YoY and by 23% from the previous quarter
Vor Biopharma's quick ratio has plunged by 57% YoY and by 23% from the previous quarter
The debt is 66% less than the equity
Vor Biopharma's debt to equity has surged by 89% YoY and by 21% QoQ
Vor Biopharma's equity has plunged by 52% YoY and by 20% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.